Answers are grounded in this paper and cite their sources.
Demonstrates effective label-free detection of Pseudomonas aeruginosa in perioperative settings, suggesting improved testing methods.
CFU/mL. The assay exhibits excellent specificity against non-target bacteria, robust stability during storage, and satisfactory anti-interference capability in complex clinical matrices. Validation using clinical samples demonstrates excellent agreement with the gold-standard colony counting method while reducing the assay time to less than 2.5 h without requiring nucleic acid extraction or thermal cycling. With its label-free design, isothermal amplification, and operational simplicity, this strategy holds great promise for point-of-care testing in perioperative settings and can be readily adapted for detecting other pathogens by substituting the corresponding aptamer.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: